Literature DB >> 31901034

[Application of 3D printing techniques in treatment of congenital heart disease].

Jiajun Xu1, Qiang Shu1.   

Abstract

Congenital heart disease (CHD) is the most common birth defect at present. In recent years, the application of 3D printing in the diagnosis and treatment of CHD has been widely recognized, which presents CHD lesions in 3D solid model and provides a better understanding of the anatomy of CHD. In the future, 3D printing technology would improve the surgical proficiency, shorten the operation time, reduce the occurrence of perioperative complications, and create more personalized cardiovascular implants, therefore promote the precision of diagnosis and treatment for congenital heart disease. This article reviews the application of 3D printing technology in preoperative planning, intraoperative navigation and personalized implants of CHD, in surgical training and medical education, as well as in promoting doctor-patient communication and better understanding their condition for patients.

Entities:  

Mesh:

Year:  2019        PMID: 31901034      PMCID: PMC8800709          DOI: 10.3785/j.issn.1008-9292.2019.10.17

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  47 in total

1.  Three-dimensional printing of intracardiac defects from three-dimensional echocardiographic images: feasibility and relative accuracy.

Authors:  Laura J Olivieri; Axel Krieger; Yue-Hin Loke; Dilip S Nath; Peter C W Kim; Craig A Sable
Journal:  J Am Soc Echocardiogr       Date:  2015-02-07       Impact factor: 5.251

2.  A novel approach to neonatal management of tetralogy of Fallot, with pulmonary atresia, and multiple aortopulmonary collaterals.

Authors:  Justin R Ryan; Tabitha G Moe; Randy Richardson; David H Frakes; John J Nigro; Stephen Pophal
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-12

3.  Surgical planning for a complex double-outlet right ventricle using 3D printing.

Authors:  Puneet Bhatla; Justin T Tretter; Sathish Chikkabyrappa; Sujata Chakravarti; Ralph S Mosca
Journal:  Echocardiography       Date:  2017-03-19       Impact factor: 1.724

4.  3D bioprinting of tissues and organs.

Authors:  Sean V Murphy; Anthony Atala
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

5.  Cardiac 3D printing for better understanding of congenital heart disease.

Authors:  Khaled Hadeed; Philippe Acar; Yves Dulac; Fabio Cuttone; Xavier Alacoque; Clément Karsenty
Journal:  Arch Cardiovasc Dis       Date:  2017-11-20       Impact factor: 2.340

6.  The role of 3D printing in preoperative planning for heart transplantation in complex congenital heart disease.

Authors:  M L Smith; J McGuinness; M K O'Reilly; L Nolke; J G Murray; J F X Jones
Journal:  Ir J Med Sci       Date:  2017-01-25       Impact factor: 1.568

Review 7.  Changing Landscape of Congenital Heart Disease.

Authors:  Berto J Bouma; Barbara J M Mulder
Journal:  Circ Res       Date:  2017-03-17       Impact factor: 17.367

8.  "Just-In-Time" Simulation Training Using 3-D Printed Cardiac Models After Congenital Cardiac Surgery.

Authors:  Laura J Olivieri; Lillian Su; Conor F Hynes; Axel Krieger; Fahad A Alfares; Karthik Ramakrishnan; David Zurakowski; M Blair Marshall; Peter C W Kim; Richard A Jonas; Dilip S Nath
Journal:  World J Pediatr Congenit Heart Surg       Date:  2016-03

9.  Clinical Application and Multidisciplinary Assessment of Three Dimensional Printing in Double Outlet Right Ventricle With Remote Ventricular Septal Defect.

Authors:  Swati Garekar; Alpa Bharati; Manish Chokhandre; Shivaji Mali; Bhadra Trivedi; Vishal P Changela; Narayan Solanki; Sarang Gaikwad; Vijay Agarwal
Journal:  World J Pediatr Congenit Heart Surg       Date:  2016-05

10.  Integration of Computed Tomography and Three-Dimensional Echocardiography for Hybrid Three-Dimensional Printing in Congenital Heart Disease.

Authors:  Jordan Gosnell; Todd Pietila; Bennett P Samuel; Harikrishnan K N Kurup; Marcus P Haw; Joseph J Vettukattil
Journal:  J Digit Imaging       Date:  2016-12       Impact factor: 4.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.